Venlafaxine-Induced Hepatotoxicity in a Patient with Ulcerative Colitis

Beytullah Yildirim; Candan Tuncer; Meltem Ergun; Selahattin Unal

2009, Number 3

<< Back Next >>

Ann Hepatol 2009; 8 (3)

Venlafaxine-Induced Hepatotoxicity in a Patient with Ulcerative Colitis

Yildirim B, Tuncer C, Ergun M, Unal S

Full text

How to cite this article

Language: English
References: 0
Page: 271-272
PDF size: 71.26 Kb.

Text Extraction

Dear Editor:

Venlafaxine-induced hepatotoxicity with notably high levels of cholestasis enzymes has rarely been described. Presence of increased cholestasis parameters in a patient with ulcerative colitis (UC) may mimic primary sclerosing cholangitis (PSC). We present here the first case of hepatotoxicity with a prominent increase in the cholestatic enzyme serum level in a patient with UC after Venlafaxine administration.